Clover Health Investments (CLOV) Common Equity (2019 - 2026)

Clover Health Investments has reported Common Equity for 8 years, with the latest figure at $339.4 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 1.0% year-over-year to $339.4 million; the trailing twelve-month figure through Mar 2026 stood at $339.4 million (up 1.0% YoY), and the FY2025 full-year result was $308.7 million, down 9.51% from the prior year.
• Common Equity for Q1 2026 stood at $339.4 million, up from $308.7 million in the prior quarter.
• The five-year high for Common Equity was $490.4 million in Q1 2022, with the low at $286.4 million in Q4 2023.
• Historically, Common Equity has averaged $347.0 million across 5 years, with a median of $339.4 million in 2026.
• Annual changes were most pronounced in 2022 — Common Equity surged 35.71% — and 2023, when it slumped 34.11%.
• Clover Health Investments' Common Equity stood at $356.9 million in 2022, then fell by 19.75% to $286.4 million in 2023, then advanced by 19.12% to $341.1 million in 2024, then fell by 9.51% to $308.7 million in 2025, then grew by 9.95% to $339.4 million in 2026.
• The last three Common Equity figures came in at $339.4 million (Q1 2026), $308.7 million (Q4 2025), and $340.9 million (Q3 2025), per Business Quant data.